Hexagon Nutrition Posts Q1 Consolidated Net Profit At ₹8.07 Crore

Market snapshot: Hexagon Nutrition Limited has reported a consolidated net profit of ₹8.07 crore (80.7 million rupees) for the first quarter ended June 30, 2026. The company's raw alert claims standalone net profit grew to ₹80.7 crore (stated as 807M; not independently verified) from ₹64.5 crore (stated as 645M; not independently verified) YoY, and Q1 revenue reached ₹100 crore (stated as 1B; not independently verified) from ₹72.8 crore (stated as 728M; not independently verified) YoY.

Data Snapshot

• Consolidated Net Profit for Q1 FY27 stood at ₹8.07 crore.
• The company listed on BSE and NSE on June 12, 2026, at an IPO issue price of ₹45 per share.
• Consolidated Net Profit for the full fiscal year 2026 stood at ₹37.94 crore.

Key Takeaways

• Hexagon Nutrition posted a consolidated net profit of ₹8.07 crore for the quarter ended June 30, 2026.
• The company debuted on the stock exchanges on June 12, 2026, following a successful public issue subscribed over 50 times.
• Historical full-year FY26 performance showed consolidated net profit at ₹37.94 crore on operations of ₹382.60 crore.

SAHI Perspective

Hexagon Nutrition's first quarterly performance post-listing highlights consolidated profitability of ₹8.07 crore. Having listed on June 12, 2026, the company is transitioning from a private entity to a public-market player. Investors should monitor whether the company can maintain this bottom-line momentum to hit its annualized historical run-rates.

Market Implications

The release of Q1 results is a key milestone for the recently listed small-cap stock. Sustained profitability should support the stock's valuation, which listed at a modest 7% premium over its ₹45 issue price. Operational stability is critical as the company seeks to build institutional trust.

Trading Signals

Market Bias: Neutral

The market bias is neutral as the reported consolidated net profit of ₹8.07 crore shows steady post-listing operations, but historical quarterly benchmarks are absent to evaluate growth momentum.

Overweight: Packaged Foods, Nutraceuticals

Trigger Factors:

• Quarterly revenue verification
• Export growth execution
• Raw material price trends of whey protein

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian clinical and wellness nutrition market has been expanding due to rising consumer health awareness and rising disposable incomes. Hexagon Nutrition operates across customized micronutrient premixes, branded clinical nutrition, and therapeutic foods, positioning it at the intersection of FMCG and healthcare.

Key Risks to Watch

• Lack of verified historical quarterly consolidated benchmarks makes short-term growth trends difficult to assess.
• Volatility in raw material costs, particularly whey protein, could impact operating margins.
• High dependency on export markets exposes the company to global geopolitical and currency fluctuation risks.

Recent Developments

In May 2026, Hexagon Nutrition secured a multi-year supply contract for micronutrient premixes with a leading African NGO, valued at ₹85 crore. The company listed on BSE and NSE on June 12, 2026, following a successful IPO priced at ₹45 per share.

Closing Insight

As a newly listed pure-play nutrition company, Hexagon's consolidated net profit of ₹8.07 crore provides a solid initial benchmark. Establishing a consistent track record of verified quarterly disclosures will be vital to attracting long-term institutional backing.

High Performance Trading with SAHI.